What a European acquirer actually buys in India
A European industrial mid-cap buying in India is usually solving one of two problems: securing upstream capacity, or entering the domestic market.
Upstream means intermediates, active pharmaceutical ingredients, speciality chemistry, precision components, capacity that currently sits with a supplier and can be owned instead. Domestic means a company with the licences, the distribution and the customer relationships that a European entity cannot assemble from Europe in any reasonable timeframe.
Origination is the work
India has no shortage of companies for sale and very little reliable information about them. Which is why origination, not execution, is where these transactions are won or lost.
Proprietary origination means building the target list before anyone sells it to you. We map the perimeter you validate, sector, state, enterprise-value range, exclusion criteria, and profile forty to eighty Indian companies against it. Ten to fifteen are qualified and scored on a grid you approve. The companies we could not access, and the ones we recommend against, are part of the deliverable.
That is the difference between a mandated buy-side boutique and an introducer. An introducer shows you the companies they happen to know, and is paid only if you buy one of them. We are paid for the search, which is what gives us the right to tell you not to buy.
Three structures, not one
Outright acquisition
Full control of an Indian company, typically a promoter-owned industrial business at a succession point or a group divesting a non-core plant.
Joint venture and minority entry
Where full control is neither available nor desirable, a negotiated joint venture with a promoter family, with governance and exit terms written at the outset rather than discovered later.
Recapitalisation and distressed
An Indian company under cash pressure, or a file inside the insolvency framework, where the timetable is set by a process rather than by the parties, and preparation decides admissibility.
Regulatory reality, analysed before the first approach
Outbound investment formalities on the European side, sectoral foreign-investment rules on the Indian side, and, on distressed files, the procedural calendar of the insolvency framework. These are analysed before we approach anyone, not after a letter of intent.
A buyer who discovers their own authorisation constraints mid-procedure is not a buyer; they are a delay. Nothing destroys value in a constrained timetable faster than a serious-looking bidder who cannot execute.
How the mandate runs
Three phases, three separate remunerations. A fixed fee for the market mapping and origination work, delivered dated and verifiable. A monthly retainer through the approach and diligence phase. A success fee at closing.
The first phase is sold on its own. A buyer who does not know us can commission three weeks of origination work, read it, and stop there.
Key takeaways
- European acquirers buy Indian upstream capacity or domestic market access, rarely both at once.
- Origination carries the transaction: reliable target information in India has to be built, not bought.
- Three structures: outright acquisition, joint venture or minority entry, recapitalisation and distressed.
- Regulatory path analysed before the first approach, on both sides of the corridor.
- Phase one is sold alone, a fixed fee, a dated deliverable, no obligation to continue.
Looking to buy an Indian company?
Open a confidential conversation. We reply on average within two business days.
Contact us